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Gender Medicine
(3) Gender Aspects on Endocrine and Metabolic Diseases: Review Including the Experiences of
Gender Medicine at the Tokyo Women’s Medical University in Japan
Miyuki Katai
Department of General and Women’s Medicine, Tokyo Women’s Medical University, Tokyo, Japan
Gender medicine (GM) deals with the effects of sex and gender differences between males and females. Since
2007, Tokyo Women’s Medical University has operated the nation’s largest Women-Specific Clinic based on GM,
at which 13 female specialists in various fields collaborate. We perform differential diagnoses of complaints while
considering gender and sex differences in the mind and in diseases, life stage, and social background. We ana-
lyzed the clinical data of 285 patients who visited us during the first year, 68% (195/285) of whom presented with
undefined complaints that included menopausal symptoms, and 26.7% (52/195) of whom were found to have or-
gan diseases which explained the undefined complaints after our differential diagnosis. Forty-three of 195 women
had endocrine diseases and 29 of them had thyroid dysfunctions; the most frequent endocrine disease. In other
words, the frequency of endocrine diseases among patients who were considered to have undefined complaints
were 22% and the corresponding frequency of thyroid dysfunction was 15%. In particular, thyroid dysfunction
symptoms overlapped with menopausal symptoms and were difficult to distinguish without thyroid function
tests. However, the endocrine test is not included in the general test, which increased the difficulty in detecting
endocrine diseases. We need to be aware that women generally have a higher incidence of endocrine disease than
men and that some endocrine diseases occur during pregnancy, postpartum, or around menopause. Incorporating
GM aspects into daily practices can improve the accuracy of the diagnosis overall, especially the diagnosis of en-
docrine diseases in women.
Key Words: gender medicine, Women-Specific Clinic, indefinite complaints, thyroid dysfunction, menopausal
symptom
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Figure　1　Changes in the hormone levels of normal women (left) and men (right) during 
the aging process.




























会（ International Society of Gender Medicine：
IGM）が中心的役割を果たしており，2006年に第 1
回国際性差医学会学術集会（IGM Congress）がベル




た IGMの主要メンバーの写真を Figure 2に示す．



















































































Table　1　Sex differences in the incidences and onset age or statuses of major endocrine and metabolic diseases.
Major endocrine and metabolic diseases Male Female Peak age or status of onset in female Reference number
Pituitary
Prolactinoma 1 3.6 20-30s (vs. 20-60s in male) 28
Acromegaly 1 1 40-50s 29
Cushing’s disease 1 4 Average age at onset 37 years in female (vs. 30 
years in male) 
28, 30
Nonfunctioning pituitary adenoma (40% of 
pituitary adenomas) 
1 1 Adults (females diagnosed earlier than male with 
amenorrhea etc.) 
31
Lymphocytic anterior pituitary inflammation 1 6 End of pregnancy, postpartum period 28, 30
Lymphocytic funnel posterior pituitary 
inflammation
1 1 No association with pregnancy or childbirth 30
Kallmann syndrome 1 0.17 No occurrence of secondary sexual characteristics 
in both boys and girls
30
Thyroid
Graves’ disease 1 4.6 20-30s 30
Hashimoto’s disease (Chronic thyroiditis) 1 20-30 30-40s 32
Subacute thyroiditis 1 8.5 40-50s 30
Painless thyroiditis (Silent thyroiditis) 1 7-9 Postpartum period 33
Thyroid cancer 1 3 40-50s (vs. 60-70s in male) 34
Parathyroid
Primary hyperparathyroidism 1 3 After middle age 30
Adrenal
Cushing syndrome 1 3.9 40-50s 30
Primary aldosteronism 1 1.5 Around 50 years old 35
Pheochromocytoma 1 1 Average age at onset 54 years (10’s to 80’s) 28
Pancreas
Insulinoma 1 1.4-1.7 60s in both male and female 36
Gastrinoma 1 0.93 50s in both male and female 37
Diabetes
Type 1 diabetes 1 2 Adolescence 38
Slowly progressive insulin-dependent 
diabetes mellitus (SPIDDM) 
1 1 Adults 32
Type 2 diabetes 1 0.5 After age 50 38
The onset frequency of women is indicated as the onset frequency of men is 1. We identified the peak onset age or status in wom-


































Figure　3　Breakdown of Disease Causes of Undefined Complaints at Women-Specific Clin-
ic of the Tokyo Women’s Medical University (2007-2008).
Modified from Katai M: Pitfalls in diagnosis and treatment of menopausal women. Journal 


























Table　2　The proportion of endocrine diseases detected among patients with indefinite 
complaints at Women-Specific Clinic of the Tokyo Women’s Medical University.
Indefinite complaints patients（n＝195） n (% of indefinite-complaints visitors) 
Patients who found the underlying organic disease 52 (27%) 
　Endocrine diseases 43 (22%) 
　　　⎧Thyroid disfunction 29 (15%) 
　　　⎨Pituitary disease  7 (3.5%) 
　　　⎩Other endocrine diseases  7 (3.5%) 
Two hundred twenty-six female patients visited our outpatient clinic from October 2007 to 





































Figure　4　Percentage of women with elevated TSH levels 
depends on age.
Adapted from reference 44.
Table　3　Similarities between menopausal symptoms and thyroid dysfunction symptoms.
Objective and 
subjective symptoms Menopause Hyperthyroidism Hypothyroidism
Heart rate Normal, but occationally palpitation Tachycardia Bradycardia
Serum cholesterol level Elevate ↗ Decrease ↘ Elevate ↗ 
Vasomotor symptoms Hot flush, Sweating, Palpitation, Coldness of 
extremity
Sweating, Palpitation Coldness of extremity
Psychiatric symptoms Anxiety, Depression, Insomnia, Irritability, 
Reduction of energy
Irritability Reduction of energy
Fatigability Yes Yes Yes
Body weight change Increase ↗ Decrease ↘ Increase ↗ 
Menstrual condition Irregular menstruation, Amenorrhea Irregular menstruation Irregular menstruation
Skin condition Dry Moist Dry
Motor symptoms Shoulder stiffness Finger tremor Tendon reflex delay
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